Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Heart Defect, Congenital
and you are
between 2 and 21
years old
The phase for this study is not defined.
Show me locations

The purpose

This is a multi-center prospective, single-arm, non-randomized, open label study to assess feasibility of the Xeltis Bioabsorbable Pulmonary Valved Conduit in subjects requiring Right Ventricular Outflow Tract correction or reconstruction due to congenital heart malformations.

Provided treatments

  • Device: Xeltis Bioabsorbable Pulmonary Valved Conduit
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03022708. The sponsor of the trial is Xeltis and it is looking for 10 volunteers for the current phase.
Official trial title:
Prospective, Non-randomized, Open Label Clinical Study to Assess the Feasibility of the Bioabsorbable Pulmonary Valved Conduit in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction